One partner for many processes to streamline your production flows: inspection, assembly, and packaging solutions. Our equipment portfolio covers every step - from laboratory-scale systems to fully automated commercial lines. With flexible platforms, advanced technologies, and reliable performance, we help you streamline processes, reduce complexity, and accelerate time to market. Learn more here 👉🏼 https://lnkd.in/dPEScgnr #StevanatoGroup #IntegratedSolutionsProvider #Equipment
Stevanato Group
Fabbricazione di prodotti farmaceutici
Piombino Dese, Padova 86.672 follower
Chi siamo
Founded in 1949, Stevanato Group is one of the world's largest providers of integrated containment and delivery solutions for the biopharmaceutical industry. From the beginning, the Group has developed its own glass forming technology to ensure quality of the highest standards. The Group includes a wide range of skills dedicated to serving the biopharmaceutical and diagnostic industry. It offers glass containers with its historic Ompi brand, plastic components for diagnostics and medical devices, contract manufacturing services for drug delivery systems, up to inspection, assembly and packaging machines. The Group also provides analytical services and tests that study the interaction between container and drug and integration into delivery sys-tems, supporting the drug development process. By bringing together several skills under the same entity, Stevanato Group is able to offer unique solutions to companies by reducing the time to market and the overall cost.
- Sito Web
-
https://www.stevanatogroup.com/
Link esterno per Stevanato Group
- Settore
- Fabbricazione di prodotti farmaceutici
- Dimensioni dell’azienda
- 5001 - 10.000 dipendenti
- Sede principale
- Piombino Dese, Padova
- Tipo
- Ditta individuale
- Data di fondazione
- 1949
- Settori di competenza
- glass pharmaceutical primary packaging, glass vials, syringes and ampoules, insulin cartridges e drug containment solutions
Località
Dipendenti presso Stevanato Group
Aggiornamenti
-
Monoclonal antibody therapies (mAbs) demand perfect compatibility between drug, container, and delivery device - a challenge across the Pharma value chain. At Stevanato Group, we simplify the process with integrated solutions: ✅ Advanced analytical services ✅ Innovative drug containment solutions and delivery devices ✅ Reliable inspection and assembly equipment Discover how we support your mAbs solutions through our expertise 👉🏼 https://lnkd.in/dMCbU9ws #StevanatoGroup #IntegratedSolutionsProvider #mAbs
-
-
We’re proud to share that we’ve been awarded the EcoVadis Silver Medal, scoring 75/100 - placing us in the top 15% of all companies assessed globally! 🌍 This recognition reflects our strong commitment to sustainability, ethics, human rights, and responsible procurement. It’s a testament to the dedication of our teams across the company who continuously embed ESG principles into everything we do. We’re more motivated than ever to keep raising the bar for a more sustainable and regenerative future. 💪🏼🌱 #Sustainability #EcoVadis #ESG
-
-
Delivering complex therapies doesn’t have to mean complex administration. Dual-chamber containment systems—available in syringe or cartridge formats—offer a streamlined solution for combination therapies and lyophilized drugs, enabling reconstitution or sequential delivery in a single, patient-friendly action. In the article “Two into one: Solving complex drug delivery problems with dual-chamber containment solutions”, Enrico Barichello and Valerio Ravazzolo explore how Stevanato Group’s help pharmaceutical partners simplify drug delivery and accelerate time to market. 📃 Read the full article: https://lnkd.in/ddZ6dz93 #StevanatoGroup #IntegratedSolutionsProvider #DualChamber
-
-
🗓 October 21–22 | 📍 Austria Center Vienna, Austria - PDA Universe of Pre-Filled Syringes & Injection Devices 2025. Visit Stevanato Group at booth #77–80 to explore our advanced drug containment and delivery systems. Don’t miss our posters and our keynote presentation on Day 1 at 5 pm with Jessica Rocco, Technical Leader DCS, and J&J talking about Cross-Industry Collaboration: A Fast and Effective Approach to Face Market Challenges for Drug Product. We look forward to welcoming you 👉🏼 book a meeting with us: https://lnkd.in/dRpaY3D8 #StevanatoGroup #IntegratedSolutionsProvider #PDA
-
📍 PODD 2025 | October 27–28 | Westin Copley Place, Boston, MA, U.S. Visit Stevanato Group at tabletop #410 during the Annual Partnership Opportunities in Drug Delivery event. Discover more about our capabilities and how we can make the difference with as an Integrated Solutions Provider. Book a meeting with us: https://lnkd.in/dDKp2VER #StevanatoGroup #IntegratedSolutionsProvider #PODD
-
Monoclonal antibodies are complex and highly sensitive drugs. Concentrated formulations can increase the risk of interaction with containers and compromise device performance. Stevanato Group provides a comprehensive offering of drug containment solutions, next-generation delivery devices, equipment, and cutting-edge analytical services. Our integrated approach safeguards the stability and efficacy of mAbs, supporting patients and partners alike. Watch the video to learn more 👇🏼 #StevanatoGroup #IntegratedSolutionsProvider #mAbs
-
📣 Just a few weeks to go: we’ll be at CPHI Frankfurt 2025! 🗓 October 28–30 | 📍 Messe Frankfurt, Germany Visit our booth n. 8.0H48 to discover how our integrated solutions support pharmaceutical companies - from early stage to commercialization. We look forward to meeting you in Frankfurt 👉🏼 Book a meeting with us: https://lnkd.in/dCgWNPCa #StevanatoGroup #IntegratedSolutionsProvider #CPHI2025
-
-
⭐️ Thank you to everyone who joined us at the Innovation Roadshow in Boston! ⭐️ It was a great opportunity to connect, share insights, and showcase how our integrated solutions support the evolving needs of the pharmaceutical industry. 📌 If you missed us, there’s another chance to connect: we’ll be attending the 15th Injectables Summit 2025, taking place today September 24 and tomorrow, September 25 in Boston. 👉🏼 We look forward to seeing you there: https://lnkd.in/dkyhBSzU #StevanatoGroup #IntegratedSolutionsProvider #InnovationRoadshow #InjectableDeviceDevelopmentSummit
-
-
We'll be at PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2025! 🗓 October 21–22 | 📍 Austria Center Vienna, Austria Visit our booth #77-80 to explore how we support the development of advanced drug containment and delivery systems. Don’t miss our posters and our keynote presentation on Day 1 at 5 pm, with Jessica Rocco, Technical Leader DCS, and J&J, talking about Cross-Industry Collaboration: A Fast and Effective Approach to Face Market Challenges for Drug Product We look forward to meeting you in Vienna! 👉🏼 Book a meeting with us: https://lnkd.in/dRpaY3D8 #StevanatoGroup #IntegratedSolutionsProvider #PDA
-
Pagine simili
Sfoglia le offerte di lavoro
Raccolta fondi
Ultimo round
Debito post-IPO234.610.710,00 USD